Tag: ImaginAb

July 24, 2019 Off

ImaginAb kicks off cancer treatment testing

ImaginAb has started the clinical trial of its lead product, CD8 tracer Zr-Df-IAB22M2C, a first in class imaging agent that visualizes the immune system using non-invasive, whole-body in vivo PET imaging of CD8 T cells.

May 16, 2019 Off

ImaginAb enrolls metastatic cancer patients for second phase testing CD8 T-cell ImmunoPET imaging agent

By Dino Mustafić

ImaginAb has enrolled its first patient for the Phase II clinical trial of its lead product, CD8 tracer 89Zr-Df-IAB22M2C, at City of Hope in Los Angeles County.